Risperidone Treatment in Dually-Diagnosed Individuals - 2

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Risperidone

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000267

P50-09236-2

NIDA-09236-2

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of risperidone for cocaine dependence in individuals with schizophrenia/schizoaffective illness.

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.